Clinical Trial Update: Efficacy and Safety of Two Fixed-dose Combinations in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. (BENIPRO) [Phase 3]

View source ↗

Summary

Two fixed-dose combination drugs are being studied in Phase 3 to assess efficacy and safety in men with Benign prostatic hyperplasia with lower urinary tract sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms | Phase 3 | Status: NOT_YET_RECRUITING